Clinica    Scrip    Scrip Regulatory Affairs    Scrip Clinical Research    Animal Pharm   
Email ID
Password
Forgotten password?
Sign me in automatically next time
Home
Market Sector
Business
Policy & Regulation
Regions
US
|
Europe
|
Latin America
|
Asia Pacific
|
World
|
clinica
Regions - Europe
French imaging market: a wealth on investment and opportunity, claims one group
08 September 2011
Generous tax incentives to support innovation development,along with the National Investment Policy launched by the government, have created an optimum environment in France that has allowed the medical imaging sector to thrive. That is the view of ...
Sole bidder dispute taints £22m Scottish radiotherapy contract for Varian
28 July 2011
Varian Medical Systems has won a £22m ($36m) contract to supply radiotherapy equipment to five health boards in Scotland through a single procurement contract. The move is significant for the way it was negotiated centrally, rather than on a ...
NICE OKs percutaneous cryotherapy for renal tumours
28 July 2011
The UK’s National Institute for Health and Clinical Excellence (NICE) has approved the use of percutaneous cryotherapy for the treatment of renal tumours. It is one of four techniques appraised in the latest round of NICE’s interventional procedures ...
Spanish ostoeoporosis vastly under-diagnosed “due to lack of bone densitometry”
26 July 2011
Poor access to bone densitometry is the main reason why less than one in five of people with ostoeoporosis in Spain are aware of their condition. The problem is exacerbated by low rates of preventive screening. So believes the Spanish national ...
GE Healthcare warns UK MPs: We lose focus on early diagnosis at our peril
26 July 2011
The NHS reform in England wends its way ever onwards. The “pause” is well in the background and the NHS Future Forum has delivered its verdict, but there is much more debate to come before Royal assent is granted to the troubled Health and Social ...
 
Winderler of change: medtech must prove its worth, insists German HTA chief
06 January 2011
2011 is already shaping up to be a pivotal year in Germany for reimbursement of innovative medical technology and for the industry’s relationship with IQWiG, the country's Institute for Quality and Efficiency in Health Care. All eyes are on new ...
Medical device directives revision: variations in national laws
06 January 2011
How successful have the EU member states been in implementing the revision of the medical device directives into national law? And has this been done in harmonised way? Alexandre Regniault, partner at the Paris office of law firm Simmons & Simmons, ...
Unexploited ways into the German market: why small is beautiful for medtech
25 February 2010
Changes to the way in which contracts are awarded for healthcare services in Germany are introducing a far greater element of flexibility. This offers an exciting new perspective, not only for payers and providers, but also for the medical device ...
 
Clinica market research: European ostomy market shows 5-7% growth 09 October 2009

The European ostomy bag/pouch market is estimated to be worth $780m and is growing at rates of mid-to-high single digits per year (5-7%), according to data compiled by Clinica. The market comprises mainly colostomy bags/pouches, ileostomy ...

German state defends reimbursement policy, says future lies in personalised med
09 June 2009
For German healthcare companies – medtech and pharma – when it comes to reimbursement, it could be worse. “The pharma industry always tells us ‘we could do better’, but in Germany, we see reimbursement as a win-win situation,” according to Hartmut ...
 
Oncophage: step to the future for vaccine therapy in melanoma
01 December 2008
Heat-shock proteins (HSPs) are a group of proteins whose expression is increased when the cells are exposed to elevated temperatures or other stressful conditions. This increase in expression is transcriptionally regulated. The function of HSPs is ...
Patent strategies for therapeutic RNAi
01 November 2008
Background: RNAi is an emerging and powerful technology with tremendous potential to treat a diverse number of diseases. There is little doubt about the potential commercial value of this technology; however, to fully exploit this potential, a ...
Colostrinin ™ : a naturally occurring compound derived from mammalian colostrum with efficacy in treatment of neurodegenerative diseases, including Alzheimer's
01 October 2008
Neurodegenerative illnesses such as Alzheimer's disease and their debilitating effects pose a major problem as their incidence increases. Although clinical management of neurodegenerative diseases usually involves symptomatic treatment, Colostrinin ...
 
 
COMPANY/ORGANISATION


Loading COMPANY/ORGANISATION ....
 
CONDITION


Loading CONDITION ....
 
GEOGRAPHY


Loading GEOGRAPHY ....
 
MEDICAL TECHNOLOGY


Loading MEDICAL TECHNOLOGY ....
 
 
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Home
Market Sector
Business
Policy & Regulation
Regions
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Clinica
Scrip
Scrip Regulatory Affairs
Scrip Clinical Research
Animal Pharm